Treatment Pattern and Overall Survival in Newly Diagnosed Multiple Myeloma Patients who are not Eligible for Autologous Stem Cell Transplantation

被引：0
|
作者：
He, Jianming [1 ]
Qiu, Lugui [2 ]
Schmerold, Luke [3 ]
Potluri, Ravi [3 ]
Li, Lin [4 ]
Hu, Peter [5 ]
Nemat, Sepideh [6 ]
Smugar, Steven S. [7 ]
Appiani, Carlos [8 ]
Mehra, Maneesha [9 ]
Richarz, Ute [10 ]
机构：
[1] Janssen, Raritan, NJ USA
[2] Chinese Acad Med Sci, Inst Hematol, Tianjin, Peoples R China
[3] Smart Analyst, New York, NY USA
[4] Xian Janssen Pharmaceut Ltd, Beijing, Peoples R China
[5] Janssen R&D, Raritan, NJ USA
[6] Janssen R&D, High Wycombe, Bucks, England
[7] Janssen R&D, Titusville, NJ USA
[8] Janssen R&D, Spring House, PA USA
[9] Janssen Global Serv, Raritan, NJ USA
[10] Janssen Global Serv, Zug, Switzerland
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
Multiple myeloma; multiple myeloma-specific survival; multiple-myeloma specific survival;
D O I：
10.1016/j.clml.2019.09.380
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-054
引用
收藏
页码：E229 / E229
页数：1
相关论文
共 50 条
  • [21] Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation
    Chakraborty, Rajshekhar
    Muchtar, Eli
    Kumar, Shaji K.
    Buadi, Francis K.
    Dingli, David
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Hogan, William J.
    Kapoor, Prashant
    Lacy, Martha Q.
    Leung, Nelson
    Warsame, Rahma
    Kourelis, Taxiarchis
    Gonsalves, Wilson
    Gertz, Morie A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 (01) : 71 - 77
  • [22] Thalidomide maintenance, is it still effective in extending survival after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma
    Kim, D. J.
    Lee, H. S.
    Kim, Y. S.
    Jung, S. M.
    Min, C. -K.
    Lee, W. S.
    Shin, H. -J.
    Lee, J. -J.
    Kim, K.
    Yoon, D. H.
    Eom, H. -S.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S19 - S20
  • [23] Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents
    Merz, M.
    Neben, K.
    Raab, M. S.
    Egerer, G.
    Hose, D.
    Sauer, S.
    Heiss, C.
    Ho, A. D.
    Goldschmidt, H.
    Hillengass, J.
    ONKOLOGIE, 2013, 36 : 152 - 152
  • [24] A SINGLE CENTRE EXPERIENCE OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA PATIENTS
    Riva, M.
    Ammirati, L.
    Visentin, A.
    Gurrieri, C.
    Branca, A.
    Scapinello, G.
    Barila, G.
    Imbergamo, S.
    Piazza, F.
    Trentin, L.
    Zambello, R.
    Semenzato, G.
    Berno, T.
    HAEMATOLOGICA, 2019, 104 : 166 - 166
  • [25] Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents
    Merz, M.
    Neben, K.
    Raab, M. S.
    Sauer, S.
    Egerer, G.
    Hundemer, M.
    Hose, D.
    Kunz, C.
    Heiss, C.
    Ho, A. D.
    Goldschmidt, H.
    Hillengass, J.
    ANNALS OF ONCOLOGY, 2014, 25 (01) : 189 - 195
  • [26] Autologous Stem Cell Transplantation in Newly Diagnosed Elderly Multiple Myeloma Patients: A Single Centre Experience
    Berno, Tamara
    Riva, Marcello
    Ammirati, Lucia
    Brugnaro, Luca
    Gurrieri, Carmela
    Branca, Antonio
    Mitja, Nabergoj
    Visentin, Andrea
    Imbergamo, Silvia
    Piazza, Francesco
    Trentin, Livio
    Zambello, Renato
    Semenzato, Gianpietro
    BLOOD, 2017, 130
  • [27] Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma
    Grieb, Nora
    Oeser, Alexander
    Ferle, Maximilian
    Hanke, Franziska
    Flossdorf, Sarah
    Sauer, Sandra
    Goldschmidt, Hartmut
    Mueller-Tidow, Carsten
    Salwender, Hans-Juergen
    Fenk, Roland
    Engelhardt, Monika
    Zeiser, Robert
    Vucinic, Vladan
    Franke, Georg-Nikolaus
    Blau, Igor Wolfgang
    Teschner, Daniel
    Einsele, Hermann
    Kimmich, Christoph
    Kull, Miriam
    Besemer, Britta
    Gagelmann, Nico
    Kroeger, Nicolaus
    Neumuth, Thomas
    Platzbecker, Uwe
    Merz, Maximilian
    BONE MARROW TRANSPLANTATION, 2024, : 335 - 345
  • [28] TREATMENT OF MULTIPLE MYELOMA IN PATIENTS ELIGIBLE FOR THE AUTOLOGOUS STEM CELL TRANSPLANTATION: MATTER OF CHOICE, RESPONSE AND EFFICACY
    Bila, J.
    Jelicic, J.
    Djurasinovic, V.
    Antic, D.
    Todorovic, M.
    Vujic, D.
    Sefer, D.
    Kraguljac, N.
    Bogunovic, M.
    Andjelic, B.
    Vukovic, V.
    Sretenovic, A.
    Gotic, M.
    Elezovic, I.
    Tomin, D.
    Mihaljevic, B.
    HAEMATOLOGICA, 2014, 99 : 654 - 655
  • [29] Magnetic resonance imaging pattern of bone marrow involvement as a new predictive parameter of disease progression in newly diagnosed patients with multiple myeloma eligible for autologous stem cell transplantation
    Song, Moo-Kon
    Chung, Joo-Seop
    Lee, Je-Jung
    Min, Chang-Ki
    Ahn, Jae-Sook
    Lee, Sang-Min
    Shin, Dong-Yeop
    Bae, Sung-Hwa
    Hong, Junshik
    Lee, Gyeong-won
    Lee, In-Sook
    Shin, Ho-Jin
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (06) : 777 - 785
  • [30] Clinical Outcomes of Newly Diagnosed Multiple Myeloma Patients with Elevated Lactate Dehydrogenase Who Underwent Autologous Hematopoietic Stem Cell Transplantation
    Bal, Susan
    Choi, Kwangmin
    Cincinnati, O. H.
    Landau, Heather
    Starczynowski, Daniel
    Girnius, Saulius
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
12345